patent extension granted | ITCI Message Board Posts


Intra-Cellular Therapies, Inc.

  ITCI website

ITCI   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  449 of 461  at  10/6/2023 2:36:26 PM  by

CyclingGuy


patent extension granted

 
Intra-Cellular Caplyta patent extension granted, says RBC Capital

RBC Capital reports based on an update in the FDA’s Orange Book that Intra-Cellular has now received a patent extension for their ‘839 patent that would bring this Caplyta patent to August 2033, or February 2034 with the likely additional pediatric extension. The firm, which says IP life “has been an important question surrounding Caplyta’s long-term cash flow generation,” has an Outperform rating and $79 price target on Intra-Cellular shares.

https://www.tipranks.com/news/the-fly/intra-cellular-caplyta-patent-extension-granted-says-rbc-capital


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...